MedPath

A clinical study to assess the effects of Homoeopathic medicines in patients with non alcoholic fatty liver disease

Phase 2
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2024/05/067829
Lead Sponsor
Government of Uttar Pradesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Individuals with Grade I to III NAFLD established by Ultrasonography and or ALT enzymes level more than 30 IU per mL in males and more than 19 IU per mL in females

Clinically diagnosed cases of Fatty Liver

Patients willing to give consent either

Exclusion Criteria

Pregnant females and lactating mothers will be excluded

Individuals not providing written informed consent for the study

Patient with existing from liver diseases like Alcoholic Fatty Liver Grade IV Non Alcoholic fatty Liver disease viral hepatitis Autoimmune liver diseases hepatocellular carcinoma

Patient with Uncontrolled Diabetes Uncontrolled Hypertension renal or cardiac disease stroke or any other serious systemic illness

Patient on any other medication

Patient with medical emergencies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Significant changes in the scores of Chronic Liver Disease Questionnaire for NAFLD/NASH(CLDQ NAFLD/NASH )Timepoint: At Baseline 4th month 8th month 12th month
Secondary Outcome Measures
NameTimeMethod
Serum ALT levelTimepoint: At Baseline 4th month 8th month 12th month;Significant changes in BARD ScoreTimepoint: At Baseline 4th month 8th month 12th month
© Copyright 2025. All Rights Reserved by MedPath